VJHemOnc is committed to improving our service to you

ASH 2019 | Fecal microbiota transfer for steroid refractory acute GvHD

VJHemOnc is committed to improving our service to you

Mohamad Mohty

Steroid refractory graft-versus-host disease (GvHD) is associated with an absence of further therapeutic options, representing an unmet clinical need. Fecal microbiota transfer (FMT) proved to be a promising treatment modality in this challenging clinical situation. Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, outlines the study of MaaT013, a standardized, pooled-donor, high-richness microbiota biotherapeutic, in patients with steroid-dependent or steroid-refractory intestinal acute GvHD. Results were quite impressive, MaaT013 provided a safe and successful treatment, supporting further exploration of this approach. This interview took place at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter